心臓移植市場：手術タイプ別、エンドユーザー別-2025-2030年の世界予測

心臓移植市場は、2023年に119億3,000万米ドルと評価され、2024年には131億米ドルに達すると予測され、CAGR 9.88％で成長し、2030年には230億9,000万米ドルに達すると予測されています。

心臓移植市場には、患者の病気や故障した心臓を健康なドナーの心臓に置き換えることに関連する医療技術や処置が含まれます。心臓移植の必要性は、従来の治療に反応しない進行した心不全症例に起因しており、患者の延命に不可欠です。用途は主に末期心疾患患者であり、健康・医療部門が主要なエンドユーザーとなっています。市場成長は、心血管疾患の罹患率の上昇、手術技術の進歩、免疫抑制療法の改善、ドナー意識向上プログラムの増加といった要因の影響を受けています。3Dプリント心臓のような技術革新や臓器保存と輸送の進歩は、移植成功率を高め、移植への地理的アクセスを増加させ、重要な市場機会を強調しています。課題としては、世界のドナー心臓の不足、移植手術の高額な費用、複雑な術後ケアの必要性などがあり、これらは治療の可用性に格差をもたらす可能性があります。臓器提供に関する規制上のハードルや倫理的な懸念は、市場の拡大をさらに複雑にしています。これらのハードルに対処するため、技術革新は人工心臓と異種移植（異種臓器移植）の開発に重点を置いており、臓器不足に対する長期的な解決策が期待されています。低侵襲手術技術、より優れた免疫抑制剤、患者選択と最適なドナーマッチングにAIを活用する研究に重点を置くことで、業界発展の道が開けると思われます。市場の競争は激しく、研究集約型であり、持続可能で革新的なソリューションの必要性に後押しされた研究機関、病院、ヘルスケア企業間の共同研究が特徴です。この市場で優位に立ち続けるには、患者の転帰とドナー臓器の利用を最適化する調査と技術への投資が必要であり、心臓移植における現在の需要と将来の課題の両方に対応できるよう、企業を位置づけています。

市場力学：急速に進化する心臓移植市場の主要市場インサイトを公開

心臓移植市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 生活の質の改善と向上に対する需要の高まり
  • 世界の高齢者人口の増加に伴う心血管疾患の有病率の上昇
  • 研究開発活動に対する政府支援の急増
• 市場抑制要因
  • 熟練した外科医の不足とドナーの不足
• 市場機会
  • 新興諸国および先進諸国における旺盛なヘルスケア支出
  • 機械的循環補助装置などの新たな応用
• 市場の課題
  • 治療費の高騰

ポーターの5つの力：心臓移植市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓移植市場における外部からの影響の把握

外部マクロ環境要因は、心臓移植市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓移植市場における競合情勢の把握

心臓移植市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓移植市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓移植市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓移植市場における成功への道筋を描く

心臓移植市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生活の質の向上と向上に対する需要の高まり
    • 世界中で心血管疾患の罹患率が上昇し、高齢者人口も増加している
    • 研究開発活動に対する政府の支援の急増
  • 抑制要因
    • 熟練外科医の不足とドナーの不足
  • 機会
    • 発展途上国と先進国におけるヘルスケア費支出の堅調さ
    • 機械的循環補助装置等の新たな応用
  • 課題
    • 治療費が高い
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓移植市場手術の種類別

• 両心室ペーシング
• 完全人工心臓
• 補助人工心臓

第7章 心臓移植市場：エンドユーザー別

• 心臓病研究所
• 病院

第8章 南北アメリカの心臓移植市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の心臓移植市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの心臓移植市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Abiomed
• Berlin Heart
• Bivacor, Inc.
• Boston Scientific Corporation
• Calon Cardio-Technology Ltd.
• CareDx, Inc.
• Edwards Lifesciences
• Fresenius Medical Care AG & Co. KGaA
• GE Healthcare
• Getinge AB
• Jarvik Heart, Inc.
• Johnson & Johnson Services, Inc.
• LivaNova, Inc.
• Medtronic PLC
• SynCardia Systems, LLC
• Terumo Europe N.V.
• Thoratec Corporation
• W. L. Gore & Associates

LIST OF FIGURES

• FIGURE 1. HEART TRANSPLANT MARKET RESEARCH PROCESS
• FIGURE 2. HEART TRANSPLANT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART TRANSPLANT MARKET DYNAMICS
• TABLE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIVENTRICULAR PACING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CARDIAC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023

The Heart Transplant Market was valued at USD 11.93 billion in 2023, expected to reach USD 13.10 billion in 2024, and is projected to grow at a CAGR of 9.88%, to USD 23.09 billion by 2030.

The heart transplant market encompasses medical technologies and procedures associated with replacing a patient's diseased or failing heart with a healthy donor heart. The necessity for heart transplants is driven by advanced heart failure cases unresponsive to conventional treatments, making it crucial for extending patients' lives. Applications predominantly involve end-stage heart disease patients, making the health and medical sectors the primary end users. Market growth is influenced by factors such as rising incidences of cardiovascular diseases, advancement in surgical techniques, improved immunosuppressive therapies, and increased donor awareness programs. Innovations like 3D-printed hearts and advancements in organ preservation and transport underscore significant market opportunities, enhancing transplant success rates and increasing geographic accessibility to transplants. Challenges include a global shortage of donor hearts, high costs of transplant procedures, and complex post-operative care requirements, which can lead to disparities in treatment availability. Regulatory hurdles and ethical concerns regarding organ donation further complicate market expansion. To address these hurdles, innovation focuses on the development of artificial hearts and xenotransplantation (cross-species organ transplants), which promise a long-term solution to organ scarcity. Emphasizing research in minimally invasive surgical techniques, better immunosuppressive drugs, and harnessing AI for patient selection and optimum donor matching will provide avenues for industry advancement. The market nature is competitive and research-intensive, characterized by collaborations between research institutions, hospitals, and healthcare companies, driven by the need for sustainable and innovative solutions. Staying ahead in this market requires investing in research and technology that optimize patient outcomes and donor organ utilization, positioning businesses to meet both current demands and future challenges in heart transplants.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Transplant Market

The Heart Transplant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for improved and extended quality of life
  • Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
  • Surge in government support for R&D activities
• Market Restraints
  • Dearth of skilled surgeons and shortage of donors
• Market Opportunities
  • Robust healthcare expenditure in developing and developed countries
  • Emerging application of mechanical circulatory support assist devices and other such devices
• Market Challenges
  • High cost of the treatment

Porter's Five Forces: A Strategic Tool for Navigating the Heart Transplant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Transplant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Transplant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Transplant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Transplant Market

A detailed market share analysis in the Heart Transplant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Transplant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Transplant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Transplant Market

A strategic analysis of the Heart Transplant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Transplant Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Berlin Heart, Bivacor, Inc., Boston Scientific Corporation, Calon Cardio-Technology Ltd., CareDx, Inc., Edwards Lifesciences, Fresenius Medical Care AG & Co. KGaA, GE Healthcare, Getinge AB, Jarvik Heart, Inc., Johnson & Johnson Services, Inc., LivaNova, Inc., Medtronic PLC, SynCardia Systems, LLC, Terumo Europe N.V., Thoratec Corporation, and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Heart Transplant Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Surgery Type, market is studied across Biventricular Pacing, Total Artificial Heart, and Ventricular Assist Devices.
• Based on End User, market is studied across Cardiac Institutes and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for improved and extended quality of life
    • 5.1.1.2. Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
    • 5.1.1.3. Surge in government support for R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of skilled surgeons and shortage of donors
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust healthcare expenditure in developing and developed countries
    • 5.1.3.2. Emerging application of mechanical circulatory support assist devices and other such devices
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of the treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Transplant Market, by Surgery Type

• 6.1. Introduction
• 6.2. Biventricular Pacing
• 6.3. Total Artificial Heart
• 6.4. Ventricular Assist Devices

7. Heart Transplant Market, by End User

• 7.1. Introduction
• 7.2. Cardiac Institutes
• 7.3. Hospitals

8. Americas Heart Transplant Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Transplant Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Transplant Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abiomed
• 3. Berlin Heart
• 4. Bivacor, Inc.
• 5. Boston Scientific Corporation
• 6. Calon Cardio-Technology Ltd.
• 7. CareDx, Inc.
• 8. Edwards Lifesciences
• 9. Fresenius Medical Care AG & Co. KGaA
• 10. GE Healthcare
• 11. Getinge AB
• 12. Jarvik Heart, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. LivaNova, Inc.
• 15. Medtronic PLC
• 16. SynCardia Systems, LLC
• 17. Terumo Europe N.V.
• 18. Thoratec Corporation
• 19. W. L. Gore & Associates